Semaglutide / Pyridoxine GLP-1 Injection

Semaglutide/Pyridoxine is a dual-action treatment combining a GLP-1 receptor agonist with Pyridoxine (Vitamin B6). It supports weight management, improves blood sugar control, and enhances overall metabolic health.

Semaglutide reduces appetite and improves insulin sensitivity by mimicking natural hormones that regulate blood sugar and hunger. Pyridoxine supports energy metabolism and helps reduce fatigue.

It is a weekly subcutaneous injection. Your healthcare provider will guide you on the correct dosing schedule and injection techniques.

Treatment begins with a lower dose to minimize side effects, progressively increasing to a therapeutic level. Your healthcare provider will adjust the dosage as needed.

Common side effects include nausea, diarrhea, and mild digestive discomfort, which often subside as your body adapts. Less common side effects may include fatigue or injection site irritation.

This medication is not recommended for individuals with a history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome type 2 (MEN 2), pancreatitis, or severe kidney disease. A medical consultation is required to determine your eligibility.